“Enter the Biosimilars”: An ACG-CCFA Webinar with Dr. David T. Rubin

Share
  • Twitter
  • Facebook
  • email
  • StumbleUpon
  • Delicious
  • Google Reader
  • LinkedIn
  • Google Bookmarks

    ACG CCFA IBD Circle banner

    ACG and CCFA Co-Hosted an IBD Circle Webinar

    Optimizing Medical Therapy in IBD:

    Enter the Biosimilars

    June 29, 2016

    Dr Rubin_007-new smal

    David T. Rubin, MD, FACG

    You can listen this webinar with David T. Rubin, MD, FACG who shares insights on how clinicians can best use the currently available medical therapies in IBD. With biosimilars on the horizon, Dr. Rubin touched on some of the potential issues related to these new therapeutic options.

    This webinar was offered through the ACG-CCFA IBD Circle, a private online community for members of ACG and CCFA.  Login required to listen to the webinar and join the discussion on the ACG-CCFA IBD Circle.

    ACCESS THE BIOSIMILARS WEBINAR

    Presenter: David T. Rubin, MD, FACG

    Joseph B. Kirsner Professor of Medicine
    Section Chief, Gastroenterology, Hepatology and Nutrition
    Co-Director, Digestive Diseases Center
    The University of Chicago Medicine

    Dr. Rubin specializes in the treatment and assessment of digestive diseases. His clinical expertise includes inflammatory bowel diseases (Crohn’s disease and ulcerative colitis) and high-risk cancer syndromes.

    Dr. Rubin performs clinical research related to outcomes in inflammatory bowel diseases, with particular interest in prevention of cancer associated with these diseases. He is also interested in new therapies for inflammatory bowel diseases and better screening tools for colorectal cancer.
    Follow Dr. Rubin on Twitter @IBDMD

    Webinar sponsored by:
    Janssen logo
    Brought to you by GoToWebinar®
    Webinars Made Easy®

    Share
    • Twitter
    • Facebook
    • email
    • StumbleUpon
    • Delicious
    • Google Reader
    • LinkedIn
    • Google Bookmarks